Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
This trial is for various types of malignancies which may depend on certain enzymes (tyrosine
kinases) for growth. The objective of this study is to assess to what extent imatinib
mesylate blocks these enzymes and to assess the effect on the malignancy.